Our IND-enabling services provide comprehensive support for drug development. For in vitro and in vivo drug metabolism and pharmacokinetics (DMPK), we conduct absorption, distribution, metabolism and excretion (ADME) studies to thoroughly evaluate your compound's pharmacokinetics. In vitro toxicology support includes genotoxicity studies to de-risk your project at an early stage. By addressing regulatory requirements and optimising study designs, we streamline the pathway to successful IND filing. Our expertise helps ensure seamless integration into clinical evaluation, reducing risks and accelerating timelines for your compound's transition into human trials.
Our DMPK team understands that every project is unique, so we offer tailored IND-enabling services specifically designed for your drug candidate. Unlike standard approaches, our customised studies can streamline development, reduce costs and improve the characterisation of your compound while helping ensure full regulatory compliance. This approach helps you move forward with confidence and precision in your drug development journey.
Contact Us
Search